Substantial preclinical evidence demonstrates the antiproliferative, cytotoxic, and
antimetastatic properties of plant-derived cannabinoids (phytocannabinoids) such as …

Preclinical models provided ample evidence that cannabinoids are cytotoxic against cancer
cells. Among the best studied phytocannabinoids, cannabidiol (CBD) is most promising for …

Cannabinoids comprise the plant-derived compounds and their synthetic derivatives as well
as endogenously produced lipophilic mediators. Phytocannabinoids are terpenophenolic …

Cannabinoids have been attracting a great deal of interest as potential anticancer agents.
Originally derived from the plant Cannabis sativa, there are now a number of endo-, phyto …

Cannabinoids—the active components of Cannabis sativa and their derivatives—exert
palliative effects in cancer patients by preventing nausea, vomiting and pain and by …

Objectives: The aim of this review is to discuss cannabinoids from a preclinical and clinical
oncological perspective and provide the audience with a concise, retrospective overview of …

Δ9-Tetrahydrocannabinol (THC) exhibits antitumor effects on various cancer cell types, but
its use in chemotherapy is limited by its psychotropic activity. We investigated the antitumor …

In the last two decades, research has dramatically increased the knowledge of cannabinoids
biology and pharmacology. In mammals, compounds with properties similar to active …

Cannabinoids are a class of pharmacologic compounds that offer potential applications as
antitumor drugs, based on the ability of some members of this class to limit inflammation, cell …

Introduction Cannabinoids are a group of terpenophenolic compounds derived from the
Cannabis sativa L. plant. There is a growing body of evidence from cell culture and animal …